STATE STREET RESEARCH FINANCIAL TRUST
NSAR-A, EX-27, 2000-10-26
Previous: STATE STREET RESEARCH FINANCIAL TRUST, NSAR-A, EX-27, 2000-10-26
Next: STATE STREET RESEARCH FINANCIAL TRUST, NSAR-A, EX-27, 2000-10-26



<TABLE> <S> <C>


<ARTICLE>                                            6
<SERIES>
   <NUMBER>  061
   <NAME>    State Street Research Health Sciences Fund - Class A

<S>                                                   <C>
<PERIOD-TYPE>                                         6-MOS
<FISCAL-YEAR-END>                                     FEB-28-2001
<PERIOD-START>                                        MAR-01-2000
<PERIOD-END>                                          AUG-31-2000
<INVESTMENTS-AT-COST>                                   1,685,759
<INVESTMENTS-AT-VALUE>                                  2,213,897
<RECEIVABLES>                                              31,426
<ASSETS-OTHER>                                             88,748
<OTHER-ITEMS-ASSETS>                                            0
<TOTAL-ASSETS>                                          2,334,071
<PAYABLE-FOR-SECURITIES>                                   56,889
<SENIOR-LONG-TERM-DEBT>                                         0
<OTHER-ITEMS-LIABILITIES>                                  53,305
<TOTAL-LIABILITIES>                                       110,194
<SENIOR-EQUITY>                                                 0
<PAID-IN-CAPITAL-COMMON>                                1,504,179
<SHARES-COMMON-STOCK>                                     141,654
<SHARES-COMMON-PRIOR>                                     124,073
<ACCUMULATED-NII-CURRENT>                                       0
<OVERDISTRIBUTION-NII>                                          0
<ACCUMULATED-NET-GAINS>                                   191,560
<OVERDISTRIBUTION-GAINS>                                        0
<ACCUM-APPREC-OR-DEPREC>                                  528,138
<NET-ASSETS>                                            2,223,877
<DIVIDEND-INCOME>                                           4,165
<INTEREST-INCOME>                                           1,911
<OTHER-INCOME>                                                  0
<EXPENSES-NET>                                             14,021
<NET-INVESTMENT-INCOME>                                    (7,945)
<REALIZED-GAINS-CURRENT>                                  196,884
<APPREC-INCREASE-CURRENT>                                 194,080
<NET-CHANGE-FROM-OPS>                                     383,019
<EQUALIZATION>                                                  0
<DISTRIBUTIONS-OF-INCOME>                                     260
<DISTRIBUTIONS-OF-GAINS>                                   43,255
<DISTRIBUTIONS-OTHER>                                           0
<NUMBER-OF-SHARES-SOLD>                                    18,094
<NUMBER-OF-SHARES-REDEEMED>                                   513
<SHARES-REINVESTED>                                             0
<NET-CHANGE-IN-ASSETS>                                    569,821
<ACCUMULATED-NII-PRIOR>                                       273
<ACCUMULATED-GAINS-PRIOR>                                  37,931
<OVERDISTRIB-NII-PRIOR>                                         0
<OVERDIST-NET-GAINS-PRIOR>                                      0
<GROSS-ADVISORY-FEES>                                       6,864
<INTEREST-EXPENSE>                                              0
<GROSS-EXPENSE>                                            83,068
<AVERAGE-NET-ASSETS>                                    1,830,373
<PER-SHARE-NAV-BEGIN>                                       13.33
<PER-SHARE-NII>                                             (0.06)
<PER-SHARE-GAIN-APPREC>                                      2.75
<PER-SHARE-DIVIDEND>                                            0
<PER-SHARE-DISTRIBUTIONS>                                    0.32
<RETURNS-OF-CAPITAL>                                            0
<PER-SHARE-NAV-END>                                         15.70
<EXPENSE-RATIO>                                              1.50



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission